PAKIANATHAN DEEPIKA
SEC insider (Form 3/4/5 filer). CIK 0001270734. Director at Theravance Biopharma, Inc. (TBPH) and 3 other issuers. 8 reported Form 4/5 transactions since Sep 2024; latest on Sep 23, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies PAKIANATHAN DEEPIKA has filed insider reports for
- Theravance Biopharma, Inc. (TBPH): Director
- Freenome, Inc. (FRNM): Director
- Karyopharm Therapeutics Inc. (KPTI): Director
- Mereo BioPharma Group plc (MREO): Director
PAKIANATHAN DEEPIKA
CIK: 0001270734
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Sep 23, 2026TBPH
Theravance Biopharma, Inc.
DispositionDirect58.1K shares- - Sep 23, 2026TBPH
Theravance Biopharma, Inc.
DispositionDirect6K shares- - Jun 12, 2026TBPH
Theravance Biopharma, Inc.
AwardDirect6K shares- - May 21, 2026KPTI
Karyopharm Therapeutics Inc.
AwardDirect15.5K shares- - Feb 26, 2026MREO
Mereo BioPharma Group plc
AwardDirectShare Options (Right to buy)
66K shares- - May 28, 2025KPTI
Karyopharm Therapeutics Inc.
AwardDirectNonstatutory Stock Option (right to buy)
4.6K shares- - May 19, 2025TBPH
Theravance Biopharma, Inc.
AwardDirect10.6K shares- - Feb 5, 2025MREO
Mereo BioPharma Group plc
AwardDirectShare Options (Right to buy)
55K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 23, 2026 |  TBPH Theravance Biopharma, Inc. | Disposition | 58,065 | - | $0 | Direct |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Disposition | 6,009 | - | $0 | Direct |
| Jun 12, 2026 | TBPH Theravance Biopharma, Inc. | Award | 6,009 | - | $0 | Direct |
| May 21, 2026 |  KPTI Karyopharm Therapeutics Inc. | Award | 15,508 | - | $0 | Direct |
| Feb 26, 2026 |  MREO Mereo BioPharma Group plc | Award Share Options (Right to buy) | 66,000 | - | - | Direct |
| May 28, 2025 | KPTI Karyopharm Therapeutics Inc. | Award Nonstatutory Stock Option (right to buy) | 4,600 | - | - | Direct |
| May 19, 2025 | TBPH Theravance Biopharma, Inc. | Award | 10,649 | - | - | Direct |
| Feb 5, 2025 | MREO Mereo BioPharma Group plc | Award Share Options (Right to buy) | 55,000 | - | - | Direct |
1-8 of 8 transactions